Cargando…

How to Protect Ovarian Function before and during Chemotherapy?

A significant number of women receive a cancer diagnosis before their age of natural menopause. Among these patients, the most frequent neoplasms are breast cancer, gynecological, and hematological malignancies. Premature ovarian insufficiency and infertility are among the most feared short- to long...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arecco, Luca, Ruelle, Tommaso, Martelli, Valentino, Boutros, Andrea, Latocca, Maria Maddalena, Spinaci, Stefano, Marrocco, Camilla, Massarotti, Claudia, Lambertini, Matteo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467797/ https://www.ncbi.nlm.nih.gov/pubmed/34575299 http://dx.doi.org/10.3390/jcm10184192

Ejemplares similares

Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women
por: Martelli, Valentino, et al.
Publicado: (2021)

Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis
por: Arecco, L, et al.
Publicado: (2022)

Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients
por: Arecco, Luca, et al.
Publicado: (2020)

Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis
por: Bonardi, Benedetta, et al.
Publicado: (2020)

The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast Cancer
por: Blondeaux, Eva, et al.
Publicado: (2021)

How I perform fertility preservation in breast cancer patients
por: Razeti, M.G., et al.
Publicado: (2021)

Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review
por: Spagnolo, Francesco, et al.
Publicado: (2021)

Long-acting gonadotropin-releasing hormone agonist trigger in fertility preservation cycles before chemotherapy
por: Massarotti, C., et al.
Publicado: (2023)

Gender-specific aspects related to type of fertility preservation strategies and access to fertility care
por: Perachino, Marta, et al.
Publicado: (2020)

The Future of Breast Cancer Research in the Survivorship Field
por: Soldato, D., et al.
Publicado: (2023)

The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition
por: Scavone, Graziana, et al.
Publicado: (2023)

Metallothionein levels in ovarian tumours before and after chemotherapy.
por: Murphy, D., et al.
Publicado: (1991)

Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer
por: Parisi, Francesca, et al.
Publicado: (2020)

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
por: Lambertini, Matteo, et al.
Publicado: (2019)

Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer
por: Anderson, Richard A., et al.
Publicado: (2022)

To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone
por: Zanardi, Elisa, et al.
Publicado: (2019)

Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma
por: Boutros, Andrea, et al.
Publicado: (2021)

Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer
por: Cattrini, Carlo, et al.
Publicado: (2020)

How I treat metastatic triple-negative breast cancer
por: Caparica, Rafael, et al.
Publicado: (2019)

Adjuvant Chemotherapy for Stage II Colon Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2020)

“No Ink on Tumor” in Breast-Conserving Surgery after Neoadjuvant Chemotherapy
por: Atzori, Giulia, et al.
Publicado: (2022)

Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
por: Piombino, Claudia, et al.
Publicado: (2020)

Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy.
por: Murphy, D., et al.
Publicado: (1992)

Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review
por: Anderson, Richard A, et al.
Publicado: (2022)

Contraception and Hormone Replacement Therapy in Healthy Carriers of Germline BRCA1/2 Genes Pathogenic Variants: Results from an Italian Survey
por: Massarotti, Claudia, et al.
Publicado: (2022)

The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature Review
por: Ferrarazzo, Giulia, et al.
Publicado: (2023)

Subclinical cardiac damage in cancer patients before chemotherapy
por: Fabiani, Iacopo, et al.
Publicado: (2021)

Re: Safety and efficacy concerns of long-acting GnRH agonist trigger for ovulation induction in oncological patients undergoing oocyte cryopreservation: a call for caution and further investigation
por: Massarotti, C., et al.
Publicado: (2023)

How to manage KPC infections
por: Bassetti, Matteo, et al.
Publicado: (2020)

Evaluation of 11‐β hydroxysteroid dehydrogenase type 1 in cutaneous fibroblasts cultures of psoriatic lesional skin before and after narrow band‐UVB phototherapy
por: Tognetti, Linda, et al.
Publicado: (2021)

Reproductive issues in carriers of germline pathogenic variants in the BRCA1/2 genes: an expert meeting
por: Buonomo, Barbara, et al.
Publicado: (2021)

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
por: Poggio, Francesca, et al.
Publicado: (2019)

Clearing the Haze: How Does Nicotine Affect Hematopoiesis before and after Birth?
por: Cool, Taylor, et al.
Publicado: (2021)

To fast, or not to fast before chemotherapy, that is the question
por: Caccialanza, Riccardo, et al.
Publicado: (2018)

Effect of Antiprogesterone RU486 on VEGF Expression and Blood Vessel Remodeling on Ovarian Follicles before Ovulation
por: Mauro, Annunziata, et al.
Publicado: (2014)

Clinical significance of circulating tumor cell related markers in patients with epithelial ovarian cancer before and after adjuvant chemotherapy
por: Yousefi, Meysam, et al.
Publicado: (2021)

Ovarian damage from chemotherapy and current approaches to its protection
por: Spears, N, et al.
Publicado: (2019)

What does cannabis do to the brain before birth?
por: Musardo, Stefano, et al.
Publicado: (2018)

Chemotherapy Associated Ovarian Failure
por: Mauri, Davide, et al.
Publicado: (2020)

The added value of CA125 normalization before interval debulking surgery to the chemotherapy response score for the prognostication of ovarian cancer patients receiving neoadjuvant chemotherapy for advanced disease
por: Liang, Wei-feng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qpm226ukad8tm20kf9f8tojc71